Glaukos Corp

6 nov. 2026, 21:02 UTC

Glaukos Corporation is seeing higher trading activity with unusually high volume, peaking earlier in the day while remaining above its 20-day moving average.

5 nov. 2026, 21:03 UTC

Glaukos Corporation shares fell sharply after a brief uptick, trading with unusually high volume while remaining above its 20-day moving average.

4 nov. 2026, 21:02 UTC

Glaukos Corporation shares are advancing, supported by strong trading volume, despite earlier pulling back from a session high. The health care equipment sector shows positive momentum.

3 nov. 2026, 20:51 UTC

Glaukos Corporation shares are declining, retracing from an earlier peak, despite remaining significantly above Monday's close amid unusually high trading volume.

2 nov. 2026, 20:56 UTC

Glaukos Corporation will be added to the S&P MidCap 400 index, a development that may enhance its visibility among investors.

30 oct. 2026, 19:42 UTC

Glaukos Corporation shares fell amid a broader market downturn, with unusually high trading volume today.

29 oct. 2026, 20:03 UTC

Stock advances after return to profitability, $2 million net income.

28 oct. 2026, 23:02 UTC

Glaukos Corporation reported record Q3 net sales of $211 million and raised its 2026 sales guidance to between $775 million and $785 million.

27 oct. 2026, 20:01 UTC

Glaukos Corporation shares are experiencing higher trading activity today, reaching a notable peak earlier in the session before pulling back slightly.

26 oct. 2026, 23:46 UTC

Glaukos Corp shares are trading higher in after-market hours, remaining near the upper end of their one-month trading range.

22 oct. 2026, 20:07 UTC

Glaukos Corp shares are declining, retracing from an early session peak to approach the day's low amid a slight overall market decline.

21 oct. 2026, 20:07 UTC

Glaukos Corp shares advanced throughout Wednesday, peaking in the afternoon before a slight pullback, remaining above their 20-day moving average.

20 oct. 2026, 20:01 UTC

Glaukos Corp shares are significantly higher, currently 7.32% above their 20-day moving average and near the upper end of their one-month range.

16 oct. 2026, 19:36 UTC

Glaukos Corp shares fell sharply, marking a notable decline since Thursday's close and currently positioned around the midpoint of its one-month trading range.

15 oct. 2026, 20:07 UTC

Glaukos Corp shares are declining, reversing an early spike to finish lower from Wednesday's close amid unusual volatility.

13 oct. 2026, 20:07 UTC

Glaukos Corp shares are declining, following a volatile intraday pattern, closing lower from Monday's close despite briefly recovering earlier in the session.

9 oct. 2026, 20:06 UTC

Glaukos reports positive Phase 4 trial results for iDose TR therapy, showing a significant reduction in intraocular pressure alongside cataract surgery, confirming safety.

8 oct. 2026, 22:55 UTC

Glaukos Corp shares declined in after-market hours, continuing a downward trend from Thursday's close and remaining below its 20-day moving average.

7 oct. 2026, 20:00 UTC

Glaukos Corp is advancing significantly with unusually high trading volume, marking a departure from recent higher daily closes since Tuesday.

6 oct. 2026, 20:07 UTC

Glaukos Corp shares are declining, trading below their 20-day moving average and near the lower end of their one-month range after earlier volatility.

1 oct. 2026, 20:07 UTC

Glaukos Corp's shares are declining, positioned near the lower end of their one-month range, after a brief spike earlier in the session.

30 sept. 2026, 20:07 UTC

Glaukos Corp shares are advancing, rebounding from an earlier pullback, amid a broader market trend of significant gains on Wednesday.

29 sept. 2026, 23:55 UTC

Glaukos Corp is trading modestly higher in after-market hours, despite fluctuations during the session, and remains below its 20-day moving average.

28 sept. 2026, 20:07 UTC

Glaukos Corp is gaining ground in today's trading session, reflecting upward momentum since Friday, despite earlier pulling back from a session high.

25 sept. 2026, 20:07 UTC

Glaukos Corp shares fell sharply, closing just below Thursday's close and approximately 9.45% below their 20-day moving average.

23 sept. 2026, 20:01 UTC

Glaukos Corporation launched a keratoconus awareness campaign with Stephen Curry, but shares fell sharply today, continuing a trend of three consecutive daily declines.

22 sept. 2026, 23:01 UTC

Glaukos Corp is advancing in after-market trading, reflecting a directional move since Tuesday's close, though it remains 6.99% below its 20-day moving average.

21 sept. 2026, 20:06 UTC

Glaukos Corp's shares are declining, remaining below their 20-day moving average and near the lower end of their one-month range despite an earlier session recovery.

18 sept. 2026, 20:02 UTC

Glaukos Corp is advancing during market hours on Friday, continuing its upward trend since Thursday's close, despite lower trading compared to earlier sessions.

17 sept. 2026, 19:36 UTC

Glaukos Corp shares fell sharply, currently at their lowest point of the day and significantly below the 20-day moving average.